Neurogene (NGNE) Accumulated Depreciation (2013 - 2018)

Neurogene (NGNE) has 6 years of Accumulated Depreciation data on file, last reported at $443000.0 in Q4 2018.

• Quarterly Accumulated Depreciation fell 17.2% year-over-year to $443000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $443000.0 (down 17.2% YoY) and the FY2018 annual result came in at $443000.0, down 17.2% from the prior year.
• Accumulated Depreciation fell to $443000.0 in Q4 2018, from $535000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $535000.0 in Q4 2017 to a low of $90000.0 in Q4 2015.
• A 5-year average of $304000.0 and a median of $277000.0 in 2014 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2015 — Accumulated Depreciation slumped 67.51% — and 2017, when it surged 205.71%.
• Tracing NGNE's Accumulated Depreciation over 5 years: stood at $277000.0 in 2014, then tumbled by 67.51% to $90000.0 in 2015, then soared by 94.44% to $175000.0 in 2016, then surged by 205.71% to $535000.0 in 2017, then dropped by 17.2% to $443000.0 in 2018.
• The last three Accumulated Depreciation figures came in at $443000.0 (Q4 2018), $535000.0 (Q4 2017), and $175000.0 (Q4 2016), per Business Quant data.